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Abstract

THE EFFECTS OF PARKINSON'S ON FlXATlONAL STABILITY
By Erin L. Mallahan, M S .
A Thesis submitted in partial fulfillment of the requirements for the degree of
Master of Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2005
Major Director: Dr. Paul A. Wetzel
Associate Professor, Department of Biomedical Engineering

Parkinson's disease (PD) is a progressive, neurological movement
disorder. The stability of eye movements in PD is not well understood but many
patients report difficulty doing tasks that require stabilized fixation and gaze. The
ability to stabilize an image on the retina is critical is acquiring visual information.
The purpose of this study was to compare the stability of fixational eye
movements of PD patients to those of age-matched controls. Eye movements
during simple fixation tasks were recorded from 66 subjects (ages 52 to 84), and
36 age-matched controls (ages 58-85). The absolute velocity of the fixational

eye movements were recorded and correlated to a clinical measure of disease
...
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progression as measured by the Unified Parkinson's Disease Rating Scale
(UPDRS). Unstable, non-rhythmic eye movements were seen in the PD patients.
There were significant differences in the absolute velocity and standard deviation
between the control group and the PD group in both the horizontal and vertical
directions. The correlation of the absolute velocity to the UPDRS was not
significant. Parkinson's disease does appear to affect the stability of eye
movements. The instabilities in the eye movements appear to precede body
tremor. This could lead to an early method for diagnosis and analysis of the
disease.

CHAPTER 1 Introduction
Parkinson's Disease

Parkinson's disease (PD) is a progressive neurodegenerative disorder,
first described in 1817 by James Parkinson, that involves a decreased level of
dopamine. Dopamine is a neurotransmitter that is produced in the brain and
controls movement and coordination. With PD, a person's dopamine production
levels begin to decrease. This is followed by the death of the cells in the brain
that produce dopamine.['] While the cause of PD is not known, some of the
physiological changes .that occur are known. One relationship affected by a
decrease in dopamine is the one between dopamine and acetylcholine. This is
normally an antagonistic relationship in which neurons are inhibiting and exciting
to regulate movement. The decrease in dopamine results in uncontrolled
excitatory impulses, which causes an imbalance of the motor systems.[*]
There are several areas of the brain that PD is thought to affect, but the
most common is the substantia nigra. The substantia nigra is a nucleus located
in the midbrain, and is divided into two parts; ,the pars re.ticulate (SNr) and the
pars compacta (SNc). Nerve cells in the SNr send dopamine to both sides of the
brain.[31There is also pathological evidence of degeneration of melanincontaining cells in the SNc. This is caused by the decrease in dopamine, as
melanin is a by-product of dopamine synthesis ['I.
1

The substantia nigra is functionally related to the basal ganglia [411which
are cell groups within the cerebral hemisphere15]. The basal ganglia modulate
signals that originate in the cerebral cortex to direct individual muscles during
voluntary movement. Damage to the basal ganglia can result in a disruption of
these movements. Common symptoms of basal ganglia-related disorders,
akinesia and bradykinesia, are also common symptoms of PD. The primary
symptoms of PD are resting tremor, rigidity, akinesia, bradykinesia, and postural
instability.
Akinesia describes a problem initiating movement. S'tudies in nonhuman
primates showed that basal ganglia are most active in the planning phase of
movement [51.Therefore, akinesia is an outward sign of the disruption in the
basal ganlia's role in the planning and generation of programmed movement.
Bradykinesia describes the slowing of movement

[61J and

is seen as a reduction in

velocity and amplitude of movement 15]. Although the resting tremor is a
commonly recognizable symptom, other symptoms of the disease can be more
debilitating for the patients. PD symptoms usually begin unilaterally, and can
progress to affecting both sides. Parkinson's is diagnosed by identifying some of
these characteristic symptoms.
There are several clinical measures used to quantify these symptoms.
These measures are generally subjective, thereby showing limitations of the
currently used scales. A more objective way of measuring the progression of the
disease could be a major asset to the study of this disease. The Unified
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Parkinson's Disease Rating Scale (UPDRS) is one of the most widely used
clinical measures. This scale was developed by incorporating parts from the
multiple scales that were previously being used. The goal of the UPDRS was to
provide a comprehensive way for clinicians to monitor disabilities and
impairments caused by PD. It is broken into four sections: Behavior and Mood,
Activities of Daily Living, Motor, and Complications. The UPDRS is currently the
most commonly used PD assessment scale, and is also widely used throughout
the world. It is commonly used as a reference in studies rating specific aspects
of PD.['] UPDRS scores for the Motor section (Ill) can range from 0 to 108. The
scores are determined by a clinician by answering a series of questions and
assigning a value of 0-4 for each question, with 0 being no disability and 4 being
severe disability. The motor section of the UPDRS covers questions on speech,
facial expression, resting tremor, postural tremor, rigidity, finger taps, hand
movements, rapidly alternating pronation and supination of hands, leg agility,
ability to arise from chair, posture, gait, postural stability, and body
bradykinesiaL8].It can then be seen, that this clinical scale does not address
visual problems.
The next most widely used rating scale for Parkinson's disease is the
Hoehn and Yahr (HY) staging scale. The scale uses stages (1-5) to evaluate
disease severity. It is over 30 years old, but was modified in the 1990s to include
0.5 increments. The stages range from unilateral impairment (Stage 1) to
bilateral impairment, postural instabilities, loss of physical independence, and
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being wheelchair or bed-bound (Stage 5). Although the HY scale accounts for
some of the major aspects of the progression of PD, it has several limitations.
The stages are limited in number and are non-linear. The scale, which weighs
postural instability as a major gauge of PD progression, does not give much
weight to other motor factors and does not give any consideration to non-motor
aspects of PD. Ig1
Although the cause of PD is not yet known, there are factors that have
been determined that play a role. The role of genetics does not appear to be
significant, although there have been reports of people within a family suffering
from PD. Some genes have been found defective in some of these people, but
the majority of PD cases are still random.[101Besides genetic factors,
environmental factors such as place of residence, source of drinking water, and
occupational or residential exposure to industrial chemicals and processes are
also thought to play a role in PD["]. Research has yet to determine what is
causing the cell death leading to PD, but some theories that have arisen are free
radicals, prompted by oxidation, cause cell death. Others suggest that there is
some dysfunction of mitochondria while others think that excitotoxicity, when
neurotransmitters become unbalanced, may be the cause. Most researchers
believe the cause is a combined effect of genetic, environmental, and biological
factors. [lo]
Parkinson's disease affects both men and women and can be found in all
ethnic, economic, and geographical groups. While as many as half of the cases

5

in the US may be undiagnosed, it is estimated that 1.5 million people in the US
suffer from PD, with 60,000 new cases being diagnosed each year. Although
some patients are diagnosed earlier, onset is usually after age 60. ['*I

A study by

Van Den Eeden, et al. studied 588 newly diagnosed cases of PD in a northern
California clinic to determine incidence rates for age, race, and gender. The
study showed the male to female ratio of incidence to be 1.9:1. The incidence
rates for both males and females rose rapidly after the age of 60. The study
found only 4% of the patients were under the age of 50. The male to female ratio
was approximately 2.0:1 in all racial groups (non-Hispanic white, Hispanic, Black,
and Asian) except Asians, where the incidence of PD was slightly higher in
females.

[I3]

The reason for this irregularity is not known, however it is suggested

that perhaps it is due to environmental factors.
There are now several treatments available for patients with PD. It is
important to know that these treatments help lessen symptoms, but there is
currently no cure for this disease. Treatment can include the use of
pharmacological treatment, surgery, or a combination of both. The most
commonly used pharmacological treatment is levodopa (L-dopa). It first became
available is the 1960's-1970's. It is initially very effective in reducing symptoms,
but the effectiveness diminishes and the side effects can be debilitating

[I4].

There are also several kinds of surgeries that patients may receive.
Ablative surgeries were the common way of treating Parkinson's beginning in the
1950s. When drugs like L-dopa were discovered, surgeries became less often
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used. When the effects of the drug became more prevalent, surgeries became
popular again. Ablative surgeries, like thalamotomies and pallidotomies use
electrodes to destroy cells in the brain that are overactive in PD patients. In the
mid-1990s a non-ablative surgery was discovered.
Deep brain stimulation (DBS) involves implanting a small lead into the
thalamus and connecting it to a small pacemaker-like device. On the end of the
lead is a multi-site stimulating electrode. This technique does not destroy cells; it
temporarily disables them by firing rapid pulses of current

[I5].

This technique has

become very popular in the last few years because it has several advantages
over ablative surgeries and because it has had very promising results. DBS is
reversible, and can be adjusted to obtain maximal benefits. It can also be
performed on both sides of the brain, while the risks of cognitive or neurological
deficits are too high to have bilateral ablative surgery [I6]. There are current
studies to determine the best place to implant the lead. There are several areas
in the brain that are currently used, including the globus pallidus internus (GPi),
the subthalamic nucleus (STN), and the ventral intermediate nucleus (VIM) of the
thalamus. VIM stimulation treats tremor well but not the other symptoms of the
disease. GPi stimulation and STN stimulation are thought to treat all of the major
symptoms [141.
Oculomotor System

Parkinson's disease is often thought of as a neurological disease that
affects the motor system, and the visual effects are often overlooked. However,
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about 40% of the fibers in the brain carry "information related to visual
so some type of visual dysfunction often occurs with damage to the brain. The
oculomotor system is very complex and involves coordination from various
aspects of the system. The saccadic system controls foveation, and the pursuit
system tries to match the eye's velocity to that of the moving target's. ["I
The fovea is the part of the retina with the greatest visual acuity. While
the region of the fovea covers a visual angle of about 2") the greatest acuity is
found in a 0.8" area of the fovea[18]. The eyes move allowing the target to fall on
The stabilization of this stationary target on the
the fovea for maximum acuity [lgl.
fovea is described as fixation. If the movement of the image on the retina
exceeds 4°/sec[201211
, vision is degraded. The length of a fixation varies with
task. A typical fixation during silent reading lasts at least 200ms, while a typical
fixation during typing lasts about 400ms

[201.

During fixation the eye is relatively

stable while information is being extracted, however, there are very small eye
movements occurring during fixation.
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Figure 1: Example of a Typical
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Tremor is a high frequency movement, typically from 30-100Hz with an
amplitude of 5 to 30-sec arc, and is not correlated between the two eyes. Drift,
which is also not correlated between the two eyes, is a low-velocity movement
with an amplitude of 1 to 5-min arc, with irregular movement and frequency.
f

Microsaccades occur once or twice each second, with an amplitude of 5-min arc.
Microsaccades are highly correlated between the two eyes. [17,19,20,221 sometimes
abnormal fixations occur resulting from slow drift, saccadic intrusion, or
nystagmus, an involuntary rhythmic oscillation of the eye [Ig1.
Saccadic eye movements are voluntary movements used to move the eye
from one position to another without following an object between the two points.
They consist of high-velocity, accurate eye movements that foveate on the
intended object. They are generated by a high frequency neural pulse that move
the eye to a new position quickly, and a tonic step that maintains the eyes in the
new position. The reaction time of the saccadic system, which refers to the time
between the target's movement onset and the onset of the saccade, is about 200
ms. Sometimes, abnormalities can be found in the saccadic system. Slowed
dynamics is when the peak velocity is slower than normal. The duration of the
saccade can also be longer during slowed dynamics. There can also be
inaccurate amplitude, when the number of dysmetric saccades increases. This
creates the need for more corrective saccades. This abnormality is sometimes
seen in PD patients. The third abnormality is delayed initiation, in which there is
an abnormally long reaction time.[''] The occurance of this abnormality increases

with age.
The pursuit system, a continuous system that is not under voluntary
control, is in control of the smooth movement tracking of objects. The pursuit
system does this by matching the eye velocity to the velocity of the moving
target. Because the eyes are foveated on the object for sustained times, there is
better resolution and more gathering of information. If there is an error in
positioning of the pursuit system, it is corrected with a saccade. The pursuit
system has a latency of 100ms. [I7]
Normal activities in which the head moves could potentially cause
smearing of images on the retina. Two systems prevent this from happening.
The vestibular system compensates for brief head movements, and the
optokinetic system compensates for prolonged head movements. These two
systems work together to allow head and body movements without affecting the
visual system. The vestibular system is important for maintaining overall body
posture, equilibrium, and muscle tone, but it is also important in maintaining the
stability of images on the retina during brief head movements. It does this by
producing eye movements that compensate for the head movements. [I7] The
compensatory system is critical in maintaining a stable gaze during normal
movements.
One of the most complex tasks involving eye movements is reading.
Reading involves many systems of the body working together because there is a
large cognitive element as well as an oculomotor element. The typical reading
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pattern resembles a staircase, as seen in Figure 2'331below. The reading pattern
of a PD patient can vary greatly from this predictable pattern. The pattern is less
If PD is shown to affect the eye's
stable and tremor can be seen (Figure 3[351).

ability to stabilize an image or if it affects the ability to have a stable gaze, the
ability to acquire the visual image can be lessened.
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Figure 3: Eye movement recording while reading for a PD patient

Aqinq and the Visual System

Aging has been found to affect the visual system in several ways. While
the fixational eye movement system does not show significant changes in
stability due to aging, the range of fixation does decrease with age. For example,
.the maximal limits of the field of fixation during adduction decrease from 57
degrees for 20-29 year olds to 54 degrees for ages 50 and older[17]. Beginning
around age 40, the lens begins to lose its elasticity and becomes more flattened
in its relaxed state. Because the lens focuses light on the retina, this change in
shape affects a person's ability to accommodate.

[51

Aging has also been shown

to affect the saccadic system. The reaction time increases with age at a rate of 1
to 2 ms per year. The peak velocity of the saccades decrease with age, but the
Affects
accuracy of the saccades has not been found to decrease with age [I7].
of aging can also be seen in the pursuit system. There is a decrease in the gain,
and increase in saccades, and a decreased initial acceleration, which can
decrease by 30% [I7].
The increase in saccadic activity is caused by an increase
in positioning errors, which are corrected by saccades. There can also be an
increase in the velocity latency, but no change has been seen in the acceleration
latency [I7].
Parkinson's Disease and the Visual System

Parkinson's disease has been shown to have an effect on the visual
system. Many PD patients complain of visual problems, but these complaints
may be overlooked as age-related complications or less important than the other
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symptoms of PD. However, more research is being done on the effects of PD on
the visual system. These effects however, can lead to drastic declines in
patients' quality of life, including problems with reading, driving, watching
television, and other daily activities. One explanation for the effect of PD on the
visual system is that the basal ganglia are affected in PD. This area of the brain
is related to eye movements, including saccadic activity. Lesions to the basal
ganglia can result in impaired stimulus-response reactions [231.
There are known effects of Parkinson's disease on the visual system.
Common abnormalities include hypometric saccades and impaired smooth
pursuit [241251181.
Steady fixation has been found to be interrupted by saccadic
intrusion[261,where the eyes make saccades instead of maintaining fixation[181.
Upward gaze has also been found to be restricted in PD pa.tients[271,
but this is
also observed in normal elderly patients[281.Corin et al. [271 reported oculomotor
abnormalities in three quarters of their PD patients. In visually guided tasks,
advanced PD patients showed prolonged mean latencies [291.Manual tracking in
PD patients have shown slowed movements and poor sinusoidal tracking as well
as a significant reduction in saccadic accuracy [241.Along with reduced saccadic
It appears that the
accuracy, slowed saccadic initiation can be seen [30,24129,251.
akinesia that is a major symptom of PD can also be seen it the oculomotor
system of patients with mild, untreated PD [241.
Chan et al. [311 studied 18 PD patients and 18 controls to determine
effects of PD on the saccadic system. They found that there were characteristics
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of saccadic eye movements that were affected by PD. The subjects were
instructed, among other tasks, to look toward a peripheral stimulus as soon as it
appeared. The PD patients were found to make more express saccades in this
task than the control group, showing that they have deficits in their ability to
inhibit automatic saccades. The author suggests that these results are
consistent with a disorder of the prefrontal basal ganglia circuit. [311 Another
study found that the amplitude of saccades increased ninety minutes following a
dose of L-dopa, showing that there may be a correlation between dopamine and
control of some ocular movements. There have also been studies to examine
the effects of dopamine loss in the retina. The levels of dopamine in the retinas
of patients with PD were less than the controls. This may show that the loss of
dopamine in the retina and some areas of the brain associated with the visual
system may be the cause of visual problems in PD patients. [21
These studies are beginning to show the effects of PD on everyday
visually related tasks. Balance, which is also affected by PD, can play a role in
visual problemsw. As stated above, reading is a very complex task that involves
several systems within the body. Fundamental to reading is the ability to
stabilize fixation and gaze. These studies may help to explain the difficulty for
PD patients to read.
Objective

The ability to fixate and control eye moments is fundamental for the
extraction of visual information. The objective of this study is to determine the
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effects of PD on the stability of fixational eye movements. The goals of this study
are to determine the effects of PD and treatments on eye movements, to
compare data with those of age-matched controls, and to correlate the data with
curren,tly used clinical measures of PD. While there have been numerous
studies on the effects of PD on the saccadic system and on the pursuit system,
the effects of the disease on fixation has been overlooked. Studying fixation is
important because the ability to stabilize fixation is critical in obtaining visual
information. It is important for the general health community to understand these
effects of the disease and how they affect patients' quality of life.

CHAPTER 2 Methods
Subjects

The subjects who participated in this study were recruited from Virginia's
Commonwealth University's Ambulatory Care Center (ACC) clinic as well as the
Parkinson's Disease Research, Education, and Clinical Center (PADRECC) at
the Hunter Holmes McGuire Veterans Affairs Medical Center (VA). The 66
subjects ranged in age from 52 to 84 years, with the average age 71.5 years, and
are comprised of 50 males and 16 females. Nineteen males and 14 females
comprised the 33 PD patients from the ACC, and 31 males and 2 females
comprised the 33 PD patients from the PADRECC. Spouses or friends
accompanying patients to the clinics were used as age-matched controls. The
importance of the age-matched controls is to have a basis of comparison for agerelated affects on the visual system. There were 36 controls, 6 males and 30
females, ranging in age from 58 to 85 years, with the average age 71.7 years.
Three males and 8 females comprised the 11 controls from the ACC, and 3
males and 22 females comprised .the 25 controls from the PADRECC.
The recruitment and testing of all subjects and controls were conducted
under protocol approved by both VCU's and the VA's IRB. Subjects were
informed of the procedures before beginning and all subjects, patients and
controls, gave informed consent about participating in the study. Patients were
15
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tested immediately before or following their scheduled clinical appointment in

which they where evaluated and given a clinical measure of disease severity
based on the motor section of the Unified Parkinson's Disease Rating Score
(UPDRS). Clinicians had the option of excluding patients who, due to cognitive
abilities could not give informed consent.
Apparatus and Setup

Horizontal and vertical eye movements of the right eye were recorded
using a pupil cornea, head-mounted eye tracking system (Vision 2000, El Mar,
Inc., Toronto, Canada). The non-collimated infrared beams, pulsed at 120 Hz,
illuminate the subject's eyes while sensors detect the two corneal reflections
(Figure 4). Because the infrared beams are non-collimated, the pupil remains
dark. A beam-splitter redirects the reflected infrared light from the eye to a twodimensional charge coupled device (CCD) array located above the eye.[321The
image of the eye as well as the corneal reflection are viewed on a small video
monitor, allowing adjustment of infrared intensity for maximum contrast. The 2D
CCD array measures the intensity of the infrared light reflected from the eye
along the rows and columns, and maps it to a three-dimensional topographical
map, where the corneal reflections appear as peaks and the pupil appears as a
sink hole. The image of the eye is then fitted to an ellipsoid and an algorithm is
used to estimate the pupillary center using the corneal reflections (Figure 5 ) . The
algorithm estimates the center of the pupil using the known op,tical center and the
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estimated visual center. This information produces a signal that is sent to a
corr~puterfor processing and viewing.

CORtL
REFLEIXW

Figure 413": Estimate of pupil center and
corneal reflections

DARK
PURL

Figure 5[321:Mapping of image onto 2D CCD
array

The head-mounted portion of the eye tracker weighs less than 300 grams
and has a measurement range is ~ 4 5 horizontally
"
and ~ 3 5 vertically.
"
The
vertical range can be less due to occlusions such as the lids or lashes. The
resolution is better than 0.2".[~*]A six-degree-of-freedom, magnetic, headtracking device (Flock of Birds, Ascension Technologies, Burlington, VT) was
attached to the top of the eye tracker, and the transmitter was located close to
the back of the head to minimize non-linearities and distortions. The head
tracker provides x, y, and z positions as well of yaw, pitch, and roll angles.

Figure 6[351:Eye and Head tracking system
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The eye and head tracking systems both sample and output data at a rate
of 120 Hz. The serial outputs of each system were linked to a ToshibaTM
notebook computer through two USB-to-serial port converters (IOGEAR Model
GUC232A). The serial interface port and experimental control program that was
used to communicate with both trackers was developed by Dr. Paul A. Wetzel.
The serial port on the eye tracker ran at 38k baud, and the head tracker at 115k
baud. The head tracker runs at a higher rate to accommodate the large amount
of data it is sampling because of the six degrees-of-freedom.

Experimental Procedures
The fixation target board is a flat black board with yellow target dots
located at 0, + 5", and + 10" in both the horizontal and vertical directions (see
Figure 7). The target board is located on a laboratory jack, enabling it to be
adjusted for each subject so the horizontal axis was lined up with their eyes.
Each subject was seated at a table in a lighted room. The eye-head tracking
system was put on each subject's head, and they were told that they should
move their head and eyes normally. The system allows the subjects to move
freely, with limited restrictions. The band is adjustable so the system fits snuggly
on the subject's head. The eye can be viewed on a small video monitor, allowing
for adjustments for position and focus. The intensity of ,the infrared beams is also
adjusted to obtain ideal contrast.
The device is calibrated for each subject before the testing begins. This
process takes less than one minute and is done by having the subject look at the
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target dots on the fixation target board in an order preprogrammed within the

system. After calibration, the subjects, seated one meter from the center of the
fixation target board, were verbally instructed to fixate on the target dots located
on the fixation target board. The test lasted about 2 minutes for a quick
assessment so as not to fatigue the subjects. Subjects were also given smooth
pursuit and compensatory tasks. This data was observed to verify the behavior
of the compensatory system was working, but was not analyzed.

Figure 713": Experimental Setup

A difficulty sometimes arises in collecting data because many of the
patients wear glasses andlor have ptosis. While the system can be used with
glasses, the data obtained is not always usable. Interference from the eyelids
occluding the majority of the pupil can make it impossible for the eye tracker to
be calibrated because it is dependent on the view of the pupil. If a subject wore
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glasses, the system was adjusted so that they could complete the experiment
with the glasses on. This is accomplished by reducing the glare of the infrared
light onto the lenses of the glasses by angling away from the beam-splitter so
that they do not interfere with the corneal reflections. Four of the subjects (2 PD
patients and 2 controls) did not have usable data due to either problems during
calibration or the data was too chaotic to be usable.
Data Analvsis

The data is complied, and the recordings are converted to binary VfPlot
files and saved in a sequential format. These files are then parsed into individual
horizontal, vertical, pupillary, x, y, z, yaw, pitch, and roll files. These recordings
can then be viewed in the VfPlot program (written by Dr. Paul A. Wetzel) as head
and eye movements. Cursors are used to obtain information from the plots such
as position, velocity, and absolute velocity measurements, as well as their
standard deviations. The cursors are manually placed at the beginning and end
of each fixation. All possible fixations had to meet certain criteria to be counted
as a fixation. They had to be greater than 125 ms to be considered and
measured as a fixation. This value was constant for all data analyzed, and was
decided based on standard fixation lengths while also considering standard
deviations of fixation lengths and effects of age or disease. Corrective saccades
less than 125 ms were not counted as fixations. The program saves the data
between each set of cursors and stores it in a file for each patient. The
information obtained from the head and eye data includes velocity, acceleration,
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position, and time. The program calculates average velocity, sum of squares,
and duration of fixation and number of points within each fixation. VfPlot
calculates the velocity at each point using a 2-point central difference method.
This method uses information from the surrounding points to calculate the value
for each point, and is unique because it provides an accurate measure of velocity
and suppresses noise through a low pass filter [361.
The VfPlot program saves the data obtained between the cursors in an
ANSI1 file which is opened in Microsoft ExcelTMfor editing and extraction of data.
The data obtained were analyzed for eye and head position and for the number
and duration of fixations, saccadic amplitude and duration, and velocity. These
data values were compared to the data of the controls. They were statistically
analyzed for differences in average absolute velocity of movement during
fixations between the patients and controls. The absolute velocity of the eye
movement was chosen as a measurement to show instabilities in the eyes.
Because some movements were positive and some negative, the velocities of
these movements would cancel each other if the average of them was taken. To
account for this, the absolute velocity was used to show the true movement of
the eye. The data was analyzed to determine any correlation between groups
and/or UPDRS ratings. The data were analyzed using the JMPTMstatistical
software.

CHAPTER 3 Results
Observational differences between the eye movements of the PD patients
and the controls were seen during initial inspection of the eye movement data
(Figures 8 and 9). The head data was inspected and showed no signs of
movement and/or tremor, so the gaze was not affected by head movement and is
due to eye position. The control group data followed very predictable patterns
and movements, while the PD data did not. The eye movements in the PD data
appeared to be unstable because the recordings were not as straight and
predictable as the control group data. As described in the literature, an
increased number of fixations in the PD group were observed. The PD patients
required more saccades to get to the desired target position.
The three recordings below show recordings of eye movements during the
simple fixation tasks. These are a representative sample of the typical, stable
fixations seen in the control group. The third recording is from an 85 year old
man. While saccadic intrusion can be seen, the fixations are stable, providing
further evidence of the age effects of the visual system.
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Figure 8: Sample recordings of eye positions for
Control group

The following five recordings are a representative sample of those
recorded from the PD group. They are showing individuals with increasing
UPDRS scores and show mildly unstable fixations to more severe unstable
fixations, to continual nystagmus that may or may not affect eye movements in
both eyes.
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Figure 9: Sample recordings of eye positions for PD
patients

Positional data was briefly analyzed to determine how useful it would be
in determining instabilities of eye movements. The largest range of eye
movements instructed in the fixation task was &20°. Figure 10 shows the
I

positional data for both the control group and the PD group. The data was
predicted to be clumped around the axis at 0, &5", &1O0,f l5", and &20°. The
actual positional data did not behave in this way. While there are concentrated
values along the horizontal and vertical axis, there are many positional data
well outside the instructed range. The figure also shows the saturation of the
device. Figure 11 shows the same data restricted to those positions less than

Positional Data

PD
Control

Mean Horizontal Position
(deg)

Figure 10: Positional data for control group and PD group.

Positional Data (Mean <30 deg)
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Figure 1I: Positional data restricted to positions less than 30".

The average number of points per fixation was higher in the control
group than the PD group (Table 1) in both the horizontal and vertical directions.
This may support the observation that PD patients require more saccades to
accomplish the same visual task. Given a time frame, if they are making more
saccades to get to a target, there is less time to spend fixating on the actual
target. Because the subjects are instructed verbally when to fixate on each
target dot, there may be some small differences in how long they were given to
fixate before the investigator called out the next target. While the average
absolute velocities are higher in the vertical direction in both the CTL and PD
groups, the average number of points per fixation does not vary with direction
of eye movement.

Direction
CTL

II

CTL

I

PD

Horizontal

I

Total # of
Points

2763

221786

Avg # of points per
fixation
80

I

Vertical

I

Total # of
Fixations

Horizontal

I

2841

I

7754

228782

1

'

557759

81

1

72

I

PD
72
7772
Vertical
559786
Table 1: The average number or points per fixation is greater i n
the CTL group i n both the horizontal and vertical direciions.
Preliminary analysis of the PD data showed a high degree of skewness as
compared to the control group (Figures 12 and 13). Because of this, parametric
methods of statistical analysis could not be used to analyze the data. The data
also did not meet the assumptions of non-parametric tests, so to correct for this,
both the PD and control group data were normalized using a logarithmic
transformation. A repeated-measures-mixed-model ANOVA test was then used
to determine any significant differences between the average absolute velocity
during fixations between the patient and control groups.
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30.

-

22.

-

15.

-

7.

-

Count

Mean Absolute Velocitv ("Is)
Box Plot

Figure 12: Distributions of
Mean Absolute Velocity of
eye movements in the
horizontal direction during
fixation for Controls and PD
patients.
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Figure 13: Distributions of
Mean Absolute Velocity of
eye movements in the
vertical direction during
fixation for Controls and PD
patients.

33

The absolute velocities of the fixational eye movements were greater in
the vertical direction in both the PD and control groups, and the standard
deviations of the movements were also greater in the vertical direction in both
groups (Figure 14 and Table 2), Instabilities within fixations were observed for a
majority of the PD patients, while only few were seen in controls. These
differences were measured using the repeated-measures-mixed-model ANOVA
test. This test showed statistically significant (0.05 level) differences of the
average absolute velocity of eye movement during fixations and the standard
deviations between the PD patients and the controls in both the horizontal and
vertical directions (Table 2).

-

o CTL

PD

A Means

o

2

4

6

Mean Absolute Velocity

a

10

('Is)

Figure 14: Scatter plot showing standard deviation of absolute velocity vs mean
absolute velocity. This figure shows the overlap between CTL and PD velocities,
but also shows that the PD group means are higher.

Velocity

y
orientation
Gro u
CTL

PD

C TL
PD

horizonta I
ve rtic a I
h c rizo nta I
vertic al

h o rizo nta I
vertical
horizontal
vertical

1.425
1.702
1.940
2.18 6

1 .I8 6
1.712
1.417
2.045
1.697
2 . 2 17
1 . 9 12
2.498
S D Velocity
gMean
95% CI
1.952
1.702
2 . 2 38
2 .O 9 9
1.831
2.4 06
2 . 48 5
2.249
2.745
2.556
2.314
2.8 23

Table 2: The geometric means (gMean, "Is) are the result of transforming
back from the logarithmic values of the absolute velocities and standard
deviations during fixation used during the statistical analysis. The
gMean differences between the PD and Control (CTL) groups are
significant at the 95% CI.

Before recording, notes about certain characteristics were taken on the
subject. Table 3 shows those patients who are DBS patients, as well as those
who are not on any PD medication. Those that complained of visual problems
are also listed. The average absolute velocity of eye movement was
calculated for each subgroup; patients not on any PD medication, patients
with DBS, and patients who complained of visual problems or problems
reading. While the average velocities were higher than the PD group in all but
one subgroup (visual problems-vertical), there were only two that were found to
be significantly different. Patients with DBS had a average velocity significantly
lower than those of the whole PD group (in the vertical direction), and patients
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who complained of visual problems had a significantly higher average velocity
than those of the whole PD group (in the horizontal direction).

I

Subiect # Notes

I

PD 4
PD 5
PD 7
PD 19
PD 29
PD 36
PD 39
PD 41
PD 42
PD 44
PD 47
PD 49
PD 50
PD 51
PD 52
PD 53
PD 61
PD 64
PD 66

without meds
recent DBS, just adjusted
bilateral DBS, visual problems during reading
bilateral DBS, complaints of visual problems
n o longer reading (former attorneyj
DBS just adjusted
problem with reading
no meds, PD for -1 yr
occasional bluriness
complaints of vision problems
no complaints of vision, but no longer reads
difficulty reading
difficulty with reading, bluriness
No PD meds, hasn't started the meds yet
no PD meds, diagnosed -1 yr ago
DBS patient, recorded after adjustment
com~lainedof visual difficultv
no PD meds
bilateral DBS

I

Table 3: Notes about some of the PD patients that were taken before
recording.

I Group

Orientation

I CTL

horizontal

1I PD

1 vertical
horizontal
1 vertical

1
1

gMean

(OJS)

I

1.425

1

1.702
1.940
2.186

1

meds

1
-

2.159
2.043

1

1

1 Visual Problems

DBS

1
1.801
1.787'

1

1

2.390*
2.140

Table 4: Comparison of gMeans between individual groups.
* indicates significant difference
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A linear regression model was used to determine if there was a correlation

between the absolute velocity during fixation and disease severity, as measured
by the UPDRS rating. The tests did not show significance in the correlation for
either direction, however there was a higher degree of correlation in the
horizontal direction than in the vertical (Figures 15 and 16). The critical
correlation coefficient is 0.2787, p = 0.05 level with 48 dof. The regression
coefficient in the horizontal direction is equal to 0.2077, and the critical
correlation coefficient in the vertical direction is equal to 0.005.

Correlation of Horizontal Absolute Velocity and UPDRS

o . o l l l l l l , l l l l l l l l l , l l l l
0.0
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Figure 15: Correlation of Horizontal Absolute Velocity during Fixation and
Clinical Measure (UPDRS).
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Figure 16: Correlation of Vertical Absolute Velocity during Fixation and
Clinical Measure (UPDRS).

CHAPTER 4 Discussion
Parkinson's patients were found to have unstable eye movements during
fixation. Because the ability to stabilize fixations is necessary in acquiring visual
information, this can lead to a decrease in quality of life, as it impacts their ability
to see clearly, including reading and watching television. This study supports
results from other studies that there are effects on the visual system from PD.
Eye movements can be analyzed in different ways, but a popular method
is using algorithms to determine where saccades, fixations, or compensatory
movements are located in the data. This is not possible with the eye movement
data for the PD patients. Even in the simple fixation tasks, their eye movements
are very unpredictable and do not follow any set pattern. Some of the analysis
becomes subjective as one tries to determine where the patient is looking and
when are they fixating. While it is important to have criteria in identifying
fixations, it may be more difficult in .the PD data to identify fixations using only
those criteria.
Initial observation of the eye movement recordings showed drama.tic
differences between the controls and the PD patients. The control group
recordings tended to appear very stable, with "clean" lines and easily identifiable
fixations. The PD data was less stable, with some data appearing difficult to
identify fixations. The recordings had many small, non-rhythmic instabilities,
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sometimes appearing as a very noisy signal. There were several PD recodings

in which rhythmic oscillations (nystagmus) was identified. These patients tended
to be further along in the progression of the disease. Other observations showed
.that PD patients made more fixations than the control groups to accomplish the
same task, and the average length of fixations were longer in the CTL group as
compared to the PD.
Methods for comparing instability in the fixational eye movements can
include using eye position, velocity, and standard deviations of these. Positional
data can be affected by individual differences between subjects, but the standard
deviation of position can give insight into instability of the eye movements. One
study showed that there was an increased standard deviation of position in
patients with PD when compared to age-matched controls [341. This supports the
findings in this study that there is an increase of instability in eye movements of
PD patients. Because of the limitations of positional data, velocity of the eye
movements, as well as the standard deviation of the velocity, was used in this
study. This allows for detection of additional movements in the eyes of PD
patients that can give insight into the instabilities seen in these patients.
The distributions of the absolute velocity in both the horizontal and vertical
directions were highly skewed for the PD data, but it was normal for the control
group, demonstrating the irregularity of the PD data. The standard deviations of
the PD data were also highly skewed. The logarithmic transformation values of
the original data were used in the statistical analysis to normalize the data. The
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repeated-measures-mixed-model ANOVA accounts for the repeated number of
fixations within each subject. The lengths of fixation were weighted in the
analysis, but when not weighted, the same trends occurred. The results of the
ANOVA test showed that there were significant differences in the geometric
/

means between the patients and controls in both the horizontal and vertical
directions. The results show (Figure 12) that there is some overlap in mean
values between the control group and the PD group; however the PD group
means are significantly higher. These results are significant because they show
that Parkinson's disease does have an effect on fixational stability
A linear regression was performed to determine the correlation between
the absolute velocity of eye movements and the clinical measure, UPDRS. A
significant correlation would demonstrate the opportunity to use eye movements
as an objective measure of disease progression. The correlation was not
significant in either direction; however, there was a disparity between the levels
of correlation between the two directions. The correlation in the horizontal
direction was very close to the significant level, while in the vertical direction, the
two measures were found to be independent with almost not correlation.
The reasons for this difference are unknown, but it may be affected by the
limited vertical movements seen in normal older patients as well as those with
Parkinson's disease. Research shows vertical eye movements become
restricted with

but horizontal eye movements do not. Age effects may be
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affecting the correlation between the velocity of the eye movements and the
UPDRS scores.
Medication may have had a large impact on the result of this study. The
subjects were not required to stop their medications for ,this study, nor were they
required to be tested during only "on" or "off" times during their medication cycle.
This may affect the study in several ways. While there were significant
differences between the absolute velocities of eye movements during fixation of
controls and patients, more significant differences may be found if the patients
were off of their medications. Medication may have also effected the correlation
of the velocity to the UPDRS. The correlation of the UPDRS rating and the
absolute velocity of eye movements during fixation were not found to be
significant, although a relationship can be seen. An accurate assessment of this
correlation would require the patients to be not only clinically evaluated, but also
tested without medications. Assuming that the medications are helping the
symptoms, the UPDRS ratings may be lower on the medication than without.
Another way to test for this correlation would be to run the study on a large
number of patients with deep brain stimulators (DBS). These patients can easily
turn on and off the device and can be assessed clinically and participate in the
study with the device on and off. As seen in Table 3, the mean absolute velocity
of the known DBS patients was significantly lower (in the vertical direction) than
the mean of the whole PD group.
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This study could be improved in several ways. The sequence in which the
subjects are instructed to fixate on the target dots should be standardized. This
would allow for easier graphical comparisons, as well as statistical analysis of
comparative positional data. The subjects, as well as controls, can be tested
multiple times over time, to record their results as the disease progresses. As
stated above, using DBS patients can be beneficial because eye movement data
can be recorded without the influence of PD medication. Testing the DBS
patients while "on" and "off" could also show what affect the DBS, and possibly
medications, may have on the stability of eye movements in the patients.
Another method for improving this study would be to measure the eye
movements or both eyes. Measuring the eye movements monocularly may be
customary in eye movement studies due to the normal behavior of eye acting in
synchronization with each other; however, because of the unusual eye
movements seen in these PD patients, it may not be a valid assumption that the
left eye is doing the same things as the right. This is particularly true with PD
patients because PD begins unilaterally and progresses to become bilateral. It
would follow that if a patient is only showing symptoms of the left side and we are
measuring the right eye, that there should be no effects of PD in their eye
movements. This however, is not what was seen in the results. This may
strengthen the hypothesis that the instabilities in the eye movements precede
outward tremor in the limbs.
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Another aspect not addressed in this study is the effect of position angle
on the stability of the eyes. The stability of eye movements at 0 compared to +5",
+10°, +15", +20°, etc., was not examined in this study, but it is known that the
eyes become less stable at large angles in either direction. Further research can
compare the stability of the eyes at different distances in PD patients and
compare that controls.
Future research can include the use of accelerometers to measure body
tremor during the study so that the data can be correlated with the eye data
obtained. The sub-sections of the UPDRS Motor section (Ill) can also be
correlated to the data individually to determine if certain sub-sections are highly
correlated to the fixation data. Another way to compare the data would be to
include a standard questionnaire as part of the study to evaluate patient's
complaints, such as problems reading, watching television, and problems with
blurriness. This qualitative analysis of their complaints can be grouped and
compared to their eye movement data to determine any correlation.
The future of this research lies in several areas. If these unstable eye
movements preceded visual signs of tremor in other parts of the body, as seen in
this study, this simple visual test can be used for early detection of Parkinson's
disease. It may also be used as a more objective clinical measure of the
progression of the disease. These results can also lead to further research into
medications including treatment for these fixation instabilities. This can also lead
to improvements in DBS technology that can allow for treatment of these visual
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instabilities as well. These improvements can lead to a better quality of life for

PD patients.

CHAPTER 5 Conclusions
In order to extract visual information, it is critical,to have the ability to
stabilize fixation and gaze. If the fixation is unstable, the images can be smeared
on the retina causing a loss of acuity and contrast sensitivity. Studies are
beginning to show that fixational stability is compromised in patients with
Parkinson's disease. This can lower the quality of life for these patients. Further
research into this area may lead to medication that can help stabilize fixation for
these patients. It is first crucial to understand what affect the disease is having
on the patients and the magnitude of what losing fixational stability means to
them.
A large amount of information acquired is through the visual system. A
deficit in this system can have profound effects on the patients' lives. Patients
can lose the ability to read, drive, watch television, or even see other people
clearly. Because the ability to stabilize fixation and gaze is so important in
acquiring information, more research needs to be done to better understand the
how Parkinson's disease affects the visual system.
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APPENDIX A

I

Avg ABSVelocity

I

Std Dev.

CTL 34

85

M

VA

1.944

2.155

3.258

CTL 35

77

M

VA

3.261

3.470

4.240

5.985

M

VA

1.533

1.343

1.955

2.136

CTL 36
MAX 85
MIN 58
AVG 71.8

Control data divided by subject

2.332

APPENDIX B
Avg ABSVelocity
( O h )

Std Dev.

MAX 84
MIN 52
AVG 71.5

PD data divided by subject
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